PALBACE
Brand Name: PALBACE®
Composition: Palbociclib (125 mg)
Manufacturer: Pfizer
Product Description
Medical Info
PALBACE® 125 mg contains Palbociclib, an advanced targeted therapy used primarily for treating specific types of breast cancer, specifically hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2-) cases. As a CDK4/6 inhibitor, it works by blocking proteins that trigger cancer cell division, effectively slowing or stopping tumor progression. Developed by Pfizer, this oral medication is typically prescribed in combination with hormonal therapies like aromatase inhibitors or fulvestrant. It represents a vital breakthrough in oncology, offering extended progression-free survival for patients navigating advanced or metastatic breast cancer
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
